To provide for the expansion of human clinical trials qualifying for the orphan drug credit.
Orphan Drug Tax Credit Act of 2006 - Amends the Internal Revenue Code to move up the date on which a taxpayer may claim the tax credit for the clinical testing of drugs for rare diseases or conditions (orphan drugs) from the date a drug is designated an orphan drug to the date the application for such designation is filed.
Introduced in House
Introduced in House
Referred to the House Committee on Ways and Means.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line